News and Comments

New Development in Amgen offer To Acquire Onyx

  Sunday, June 30, 2013

In a new development, Onyx (ONXX) confirmed Amgen’s offer in the same release that announced rejecting it. Indeed, Onyx has rejected Amgen’s unsolicited proposal that suggests acquiring Onyx’s outstanding shares and share equivalents for $120 per share in cash, subject to due diligence and other conditions.  More...

ONYX TAKEOVER WAS EXPECTED

  Sunday, June 30, 2013

In November 2011 Prohost posted an article titled “Deal or no deal, time for a payoff” (click HERE to read the article). All that prophesized in that article about Onyx’ (ONXX) drugs and prospects has materialized and the final item, a takeover, seems to be on the verge of happening.   More...

Two Small Great Biotechs Underestimated by the Market

  Tuesday, June 25, 2013

Seattle Genetics’ (SGEN) and ImmunoGen’s (IMGN) conjugated monoclonal antibody therapeutics for cancer are increasingly validating their superior safety and efficacy over other cancer products that are used without the antibody drug conjugates (ADC).  More...

Why Amgen and Cytokinetics Agreement is Good News?

  Wednesday, June 12, 2013

NEWS WE WERE WAITING FOR More...


Recent Postings


Archive


Tags

Valeant Pharmaceuticals International (VRX) Alder Biopharmaceuticals (ALDR) KERYX (KERX) Rapamune GUARDIAN HEALTH ImmunoGen (IMGN) Theravance (THRX) Sangamo (SGMO) Array Pharmaceuticals (ARRY) Incyte (INCY) Genentech KITE (KITE) Mirati Therapeutics (MRTX) Regeneron (REGN) Human Longevity (HLI) Endometrial Cancer CompuGen (CGEN) REGULUS (RGLS) Biocryst (BCRX) galapagos (GLPG) PTC Therapeutics (PTCT) Biogen Idec (BIIB) HALOZYME (HALO) NANTKWEST (NK) Prosensa (RNA) Velcade (bortezomib) Aimmune Therapeutics (AIMT) RenenxBio (RGNX) IDERA (IDRA) Ridaforolimus Intrexon (XON) Telaprevir GlaxoSmithKline (GSK) Inovio (INO) Amgen (AMGN) Pluristem (PSTI) Merck (MRK) Editas (EDIT) JUNO (JUNO) ZALTRAP™ Dynavax (DVAX) BIOMARIN (BMRN) AERIE PHARMACEUTICALS ACADIA (ACAD) Exelixis (EXEL) Roche (ROCHE) Benlysta (belimumab) Auspex (ASPX) Intercept (ICPT) Vitae Pharmaceuticals (VTAE) Alnylam (ALNY) VANDA (VNDA) C4 Therapeutics Tysabri SERES THERAPEUTICS (MCRB) Sarepta (SRPT) Dendreon (DNDN) ISIS (ISIS) Jazz Pharmaceuticals (JAZZ) Intermune (ITMN) Ziofpharm (ZIOP) Bristol-Myers Squibb (BMY) Anadys (ANDS) Agenus (AGEN ABBVIE (ABBV) Spike Therapeutics (ONCE) Illumina (ILMN) OSI (OSIP) Human Genome Sciences (HGSI) Xoma (XOMA) Revlimid (lenolidamide) ADVENTRIX (ANX) ARCA (ABIO) NEKTAR (NKTR)) Vertex (VRTX) Prolor Biotech (PBTH) Sanofi (SNA) Multiple Myeloma NOVOCURE (NVCR) SUNESIS PHARMACEUTICALS (SNSS) Ariad (ARIA) Elan (ELN) Herceptin Sanofi-Aventis (SAN) ARGOS (ARGS) Seattle Genetics (SGEN) Cytokinetics (CYTK) Sequenom (SQNM) Onyx (ONXX) SYNTA (SNTA) Idenix (IDIX) Roche (RHHBY) Ionis (IONS) Abbott Laboratories (ABT) Global Cell Therapeutics (GBT) Theravance Bio Pharma (TBPH) TOKAI (TKAOI) Micromet (MITI) Agenus (AGEN) Trastuzumab-DM1 Anacor (ANAC) Sanofi (SNY) AGOS (ARGS) INNOVIVA (INVA) Zerenex Galena (GALE) Gilead (GILD)